Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing.
Lebedeva A, Veselovsky E, Kavun A, Belova E, Grigoreva T, Orlov P, Subbotovskaya A, Shipunov M, Mashkov O, Bilalov F, Shatalov P, Kaprin A, Shegai P, Diuzhev Z, Migiaev O, Vytnova N, Mileyko V, Ivanov M. Lebedeva A, et al. Among authors: belova e. World J Oncol. 2024 Aug;15(4):562-578. doi: 10.14740/wjon1820. Epub 2024 Jun 11. World J Oncol. 2024. PMID: 38993246 Free PMC article.
Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience.
Lebedeva A, Kuznetsova O, Ivanov M, Kavun A, Veselovsky E, Belova E, Mileyko V, Yakushina V, Shilo P, Tryakin A, Rumyantsev A, Moiseenko F, Fedyanin M, Nosov D. Lebedeva A, et al. Among authors: belova e. Heliyon. 2024 Apr 26;10(9):e30303. doi: 10.1016/j.heliyon.2024.e30303. eCollection 2024 May 15. Heliyon. 2024. PMID: 38707351 Free PMC article.
Failure of immune checkpoint inhibitors for microsatellite instability-positive pancreatic adenocarcinoma with atypical pattern of short tandem repeat mutation.
Babayan A, Ledin E, Lebedeva A, Kuznetsova O, Kravchuk D, Grigoreva T, Belova E, Kavun A, Mileyko V, Tryakin A, Fedyanin M, Ivanov M. Babayan A, et al. Among authors: belova e. Immunotherapy. 2024;16(13):853-858. doi: 10.1080/1750743X.2024.2376516. Epub 2024 Jul 23. Immunotherapy. 2024. PMID: 39041702
Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance.
Lebedeva A, Belova E, Kavun A, Taraskina A, Bartoletti M, Bièche I, Curigliano G, Dupain C, Rios-Hoyo A, Kamal M, Luchini C, Poyarkov S, Le Tourneau C, Veselovsky E, Mileyko V, Ivanov M. Lebedeva A, et al. Among authors: belova e. Mol Diagn Ther. 2025 Jan;29(1):91-101. doi: 10.1007/s40291-024-00748-4. Epub 2024 Oct 5. Mol Diagn Ther. 2025. PMID: 39368036
Evaluation of blood MSI burden dynamics to trace immune checkpoint inhibitor therapy efficacy through the course of treatment.
Veselovsky E, Lebedeva A, Kuznetsova O, Kravchuk D, Belova E, Taraskina A, Grigoreva T, Kavun A, Yudina V, Belyaeva L, Nikulin V, Mileyko V, Tryakin A, Fedyanin M, Ivanov M. Veselovsky E, et al. Among authors: belova e. Sci Rep. 2024 Oct 8;14(1):23454. doi: 10.1038/s41598-024-73952-1. Sci Rep. 2024. PMID: 39379462 Free PMC article.
205 results